These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3260415)

  • 21. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.
    Nitu-Whalley IC; Riddell A; Lee CA; Pasi KJ; Owens D; Enayat MS; Perkins SJ; Jenkins PV
    Thromb Haemost; 2000 Dec; 84(6):998-1004. PubMed ID: 11154147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A competitive ELISA technique for the measurement of von Willebrand factor antigen (vWF:Ag) using staphylococcal protein A peroxidase.
    Brien WF; Stewart MW
    Clin Biochem; 1986 Jun; 19(3):179-82. PubMed ID: 3488141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of avidin-biotin complex in an ELISA system: a quantitative comparison with two other immunoperoxidase detection systems using keratin antisera.
    Madri JA; Barwick KW
    Lab Invest; 1983 Jan; 48(1):98-107. PubMed ID: 6185760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody to von Willebrand factor in systemic lupus erythematosus.
    Soff GA; Green D
    J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program.
    Hayes TE; Brandt JT; Chandler WL; Eby CS; Kottke-Marchant K; Krishnan J; Lefkowitz JB; Olson JD; Rund CR; Van Cott EM; Cunningham MT
    Semin Thromb Hemost; 2006 Jul; 32(5):499-504. PubMed ID: 16862523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Avidin-biotin-peroxidase complex enzyme-linked immunosorbent assay in the diagnosis of human multilocular echinococcosis].
    Zhang JY; Sun ZG; Li M; Yang YR; Huang JA; Liu JX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1989; 7(3):197-200. PubMed ID: 2591036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The von Willebrand factor self-association is modulated by a multiple domain interaction.
    Ulrichts H; Vanhoorelbeke K; Girma JP; Lenting PJ; Vauterin S; Deckmyn H
    J Thromb Haemost; 2005 Mar; 3(3):552-61. PubMed ID: 15748246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
    Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
    Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.
    Rumley A; Lowe GD; Sweetnam PM; Yarnell JW; Ford RP
    Br J Haematol; 1999 Apr; 105(1):110-6. PubMed ID: 10233372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction.
    Villa P; Iborra J; Serra J; Gilsanz A; Casaña P; Aznar JA; Aznar J
    Haematologica; 2001 Nov; 86(11):1180-5. PubMed ID: 11694404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs.
    Sabino EP; Erb HN; Catalfamo JL
    Am J Vet Res; 2006 Feb; 67(2):242-9. PubMed ID: 16454628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates.
    Menache D; Aronson DL
    Thromb Haemost; 1997 Jul; 78(1):566-70. PubMed ID: 9198217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
    Favaloro EJ; Bukuya M; Martinelli T; Tzouroutis J; Duncan E; Welldon K; Collecutt M; Aumann H; Thom J; Gilmore G
    Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
    Vischer UM; Ingerslev J; Wollheim CB; Mestries JC; Tsakiris DA; Haefeli WE; Kruithof EK
    Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of antibodies to hepatitis B surface antigen (HBsAg) using monoclonal antibody and the avidin-biotin system.
    Korec E; Hlozánek I; Mach O; Stará J; Nĕmecek V; König J
    Folia Biol (Praha); 1986; 32(6):377-83. PubMed ID: 3803624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.